FDA.reportPublic FDA data

Careland Lidocaine 4% Pain Relieving Gel Patches

Manufacturer
Planet (Anhui) Pharmaceutical Co., Ltd.
Effective date
2024-10-17
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 20:51:59

Label at a glance#

ProductCareland Lidocaine Pain Relieving
Active ingredientLIDOCAINE
Label structure8 sections

Dosage and administration

Adults and children 12 years of age and over: clean and dry affected area remove film from patch and apply to the skin apply 1 patch at a time to affected area, not more than 3 to 4 times daily Children under 12 years of age: consult a doctor

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 4.0%

Purpose

OTC - PURPOSE SECTION

Topical anesthetic

Use

INDICATIONS & USAGE SECTION

For temporary relief of pain

WARNINGS

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  • more than 1 patch at a time
  • on wounds or damaged skin
  • with a heating pad
  • if you are allergic to any ingredients of this product

When using this product

OTC - WHEN USING SECTION

  • use only as directed
  • do not bandage tightly
  • avoid contact with the eyes, mucous membranes or rashes

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • symptoms persist for more than 7 days
  • conditions worsen
  • symptoms clear up and occur again within a few days
  • localized skin reactions, such as rash, itching, redness, pain, swelling and blistering develop

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years of age and over:

  • clean and dry affected area
  • remove film from patch and apply to the skin
  • apply 1 patch at a time to affected area, not more than 3 to 4 times daily

Children under 12 years of age:consult a doctor

OTHER INFORMATION

SPL UNCLASSIFIED SECTION

  • Store in a clean, dry place outside of direct sunlight. Protect product from excessive moisture

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Propylene Glycol, PEG-40 Hydrogenated Castor Oil, Vanillyl Butyl Ether, Phenoxyethanol, 3-2-(Ethylhexyl)oxyl-1, 2-Propandiol, Glycerol, Azone, a-Tocopherol Acetate, Sodium Polyacrylate, Dihydroxyaluminum Aminoacetate, CMC-2Na, Titanium Dioxide, Fumed Silica, Tartaric Acid, Polyacrylic Acid, Urea, Water

QUESTIONS?

OTC - QUESTIONS SECTION

1-888-655-1558 Service@getcareland.com

Package Labeling:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Label0Label0

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
75568-02075568-020-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Name, UNII, Kind table
NameUNIIKind
PROPYLENE GLYCOL6DC9Q167V3IACT
POLYOXYL 40 HYDROGENATED CASTOR OIL7YC686GQ8FIACT
VANILLYL BUTYL ETHERS2ULN37C9RIACT
PHENOXYETHANOLHIE492ZZ3TIACT
GLYCERINPDC6A3C0OXIACT
LAUROCAPRAM1F3X9DRV9XIACT
DIHYDROXYALUMINUM AMINOACETATEDO250MG0W6IACT
TITANIUM DIOXIDE15FIX9V2JPIACT
TARTARIC ACIDW4888I119HIACT
UREA8W8T17847WIACT
WATER059QF0KO0RIACT
LIDOCAINE98PI200987ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
255158fb-1634-a08e-e063-6394a90acc5a8600d434-bf02-4ad1-bf99-ca9ae1b4ad102024-10-25WarningsExact identifier
spl set id: 8600d434-bf02-4ad1-bf99-ca9ae1b4ad10

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.